Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 170.00 |
Low | 170.00 |
Bid | -- |
Offer | -- |
Previous close | 170.00 |
Average volume | -- |
---|---|
Shares outstanding | 51.50m |
Free float | 49.40m |
P/E (TTM) | -- |
Market cap | 260.06m USD |
EPS (TTM) | -3.06 USD |
Data delayed at least 20 minutes, as of Apr 28 2023 12:30 BST.
More ▼
Press releases
- 2seventy bio to Participate in the 2024 Morgan Stanley Global Healthcare Conference
- 2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress
- 2seventy bio to Report Second Quarter 2024 Financial Results on August 7, 2024
- 2seventy bio Announces Sale of Hemophilia A Candidate and MegaTAL In Vivo Gene Editing Technology to Novo Nordisk for up to $40 million